EASL Session Title: Category 02b: Cirrhosis and its complications: Clinical aspects
Presentation Date: 31 MAR, 2011
DIFFERENT PATTERN OF DECOMPENSATION IN ALCOHOLIC VERSUS NON-ALCOHOLIC LIVER CIRRHOSIS
M. Kuehne1*, J. Wiegand1, P. Pradat2, J. Moessner1, F. Zoulim2, C. Trepo2, H.L. Tillmann1,3
1Gastroenterology and Rheumatology, University of Leipzig, Leipzig, Germany, 2Department of Hepatogastroenterology, Hôtel Dieu Hospital University, Lyon, France, 3Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA. *johannes.wiegand@medizin.uni-leipzig.de
Background: The clinical course of alcoholic versus non-alcoholic liver cirrhosis has not been well described yet. However, hepatic decompensation may be differentiated either in consequences of fibrosis (i.e. jaundice, variceal bleeding) or in lack of function (i.e. ascites) resulting in variable morbidity and mortality. We therefore evaluated the pattern of decompensation in relation to the etiology of liver cirrhosis.
Patients and methods: 220 cirrhotic German patients hospitalized between 2002 and 2006 were retrospectively evaluated (cohort A). Results were confirmed in a second cohort of German and French patients (cohort B: n=217) and in an overall analysis. Hepatic decompensation was defined as presence of either ascites, jaundice, encephalopathy, variceal bleeding, hepatorenal syndrome, spontaneous bacterial peritonitis, or hepatocellular carcinoma.
Results: In cohort A and B, alcoholic cirrhosis was present in 76.4% and 73.7% of cases. 8.9% of cases were in Child status A, 30.2% status B, and 44.6% status C (p=n.s.).
Compared to non-alcoholic cirrhosis (cryptogen n=37, HCV n=30, HBV n=11, other n=31), alcoholics (n=328) were significantly younger (55.6y ± 11.5 vs. 62.4y ± 12.8, p=0.000), more often male (75.9% vs. 53.2%; p=0.000) and smokers (60.8% vs. 28.8%; p=0.000).
Alcoholics were significantly more frequently hospitalized for ascites (cohort A: 56.5% vs. 38.5%, p=0,023; cohort B 53.2% vs. 36.8%, p=0.042; total: 54.6% vs. 37.6%; p=0.002) and showed a higher incidence of spontaneous bacterial peritonitis (total: 8.9% vs. 2.8%; p=0.033) compared to non-alcoholics. Non-alcoholics presented with significantly higher rates of hepatocellular carcinoma (31.2% vs. 17.2%; p=0.002). There were no significant differences in jaundice, variceal bleeding, hepatorenal syndrome, or encephalopathy.
A subgroup analysis of alcoholic vs. viral hepatitis confirmed ascites as dominant decompensation in alcoholics (54.6% vs. 36.6%; p=0.03).
In alcoholic cirrhosis, survival did not differ between cases with or without ascites (p=0.957). However, it was significantly impaired once ascites occurred in non-alcoholic disease (p< 0.001).
Conclusions: Ascites is the leading initial pattern of decompensation in alcoholic cirrhosis whereas hepatocellular carcinoma dominates in non-alcoholics. Non-Alcoholics developing ascites show a poor survival.
http://www1.easl.eu/easl2011/program/Posters/Abstract48.htm
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment